Adult Stem Cell Doc Blog

Two teams of UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their stem cell based strategies for treating diabetes and brain tumors. The intent of the grants is for teams to file new drug applications to the U.S. Food and Drug Administration within four years, driving potential therapies toward clinical trials. The two grants, awarded to collaborative scientific teams, total $39.2 million.

U.S. District Judge Royce Lamberth on Tuesday dismissed a lawsuit challenging the Obama administration's move this year to ease federal restrictions on embryonic stem cell research, the AP/Seattle Times reports.

The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University's Berman Institute of Bioethics. In a letter published Oct. 28 in Regenerative Medicine, the authors advocate for clear ethical oversight of this research and pose key questions that warrant careful consideration.